Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targetsMarion Travert(Inserm), Philippe Gaulard(Inserm)BloodApril 18, 201210.1182/blood-2011-12-396150Cited by 107SaveCiteExport RISWatch citationsRelated PapersPrognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)|Blood|1996|417Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)|Blood|1996|411Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type|Blood|2009|310